NCT06608446 Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery
| NCT ID | NCT06608446 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Campus Bio-Medico |
| Condition | Breast Neoplasms |
| Study Type | INTERVENTIONAL |
| Enrollment | 155 participants |
| Start Date | 2023-05-15 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 155 participants in total. It began in 2023-05-15 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The most common complaints after breast surgery are postoperative pain reported in up to 68% of patients, musculoskeletal problems in the shoulder and functional limitations in up to 59% of patients after mastectomy and quadrantectomy, reduction in range of motion ( ROM) in 24-53% and strength deficit. The study aims to verify the effectiveness of a telerehabilitation treatment in terms of prevention of possible complications following breast cancer surgery. Primary objective: to examine whether the group of patients undergoing rehabilitation surgery in the immediate post-operative period shows a reduction in the onset of complications compared to the group of patients who followed standard procedures. Secondary objective: to study any preoperative prognostic factors for the onset of complications, to study the effectiveness of the rehabilitation treatment in terms of reduction of painful symptoms, improvement of joint ROM, muscle strength and perceived quality of life.
Eligibility Criteria
Inclusion Criteria: * diagnosis of breast cancer * Having undergone quadrantectomy or mastectomy surgery * Age \> 18 years * Signature of informed consent Exclusion Criteria: * Neurological deficits with sensorimotor impairment of the upper limb * Cognitive deficits that prevent the completion of questionnaires (MMSE\>24)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06608446 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06608446 currently recruiting?
Yes, NCT06608446 is actively recruiting participants. Contact the research team at s.sterzi@policlinicocampus.it for enrollment information.
Where is the NCT06608446 trial being conducted?
This trial is being conducted at Roma, Italy.
Who is sponsoring the NCT06608446 clinical trial?
NCT06608446 is sponsored by Fondazione Policlinico Universitario Campus Bio-Medico. The trial plans to enroll 155 participants.